Concepedia

Publication | Closed Access

GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial

DOI

70

Citations

7

References

1999

Year

S.J. Simmons, B.A. Tjoa, M. Rogers, A. Elgamal, Gerald M. Kenny, Haakon Ragde, M.J. Troychak, Alton L. Boynton, G.P. Murphy
The Prostate

Abstract

Our results suggest GM-CSF as employed in this trial did not detectably enhance clinical response to DC-peptide infusions, or significantly enhance the measured immune response.

References

YearCitations

Page 1